The study is to assess treatment with sofosbuvir, velpatasvir and GS-9857 in people who were previously treated with a direct-acting antiviral medication but who were not cured. Epclusa plus GS-9857 are the drugs being tested.
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Subjects With Previous DAA Experience (RESOLVE)
To view the entire clinical trial information, click here
Share This Page